Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Official Title: Repurposing Valsartan May Protect Against Pulmonary Hypertension
Brief Summary: This is a Phase 2, single-center, randomized placebo controlled trial of valsartan (an angiotensin receptor blocker) in adults with pulmonary arterial hypertension.
The study will evaluate the safety and clinical efficacy of a 24-week course of valsartan.